Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin
Hepatology Research 46(5) (2016)
Masanori Atsukawa; Akihito Tsubota; Noritomo Shimada; Kai Yoshizawa; Hiroshi Abe; Toru Asano; Yusuke Ohkubo; Masahiro Araki; Tadashi Ikegami; Tomomi Okubo; Chisa Kondo; Yuji Osada; Katsuhisa Nakatsuka; Yoshimichi Chuganji; Yasushi Matsuzaki; Katsuhiko Iwakiri; Yoshio Aizawa
Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C
Digestive and Liver Disease 46(8) (2014)
Masanori Atsukawa; Akihito Tsubota; Noritomo Shimada; Hiroshi Abe; Chisa Kondo; Norio Itokawa; Ai Nakagawa; Katsuhiko Iwakiri; Chiaki Kawamoto; Yoshio Aizawa; Choitsu Sakamoto
Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients
BMC Infectious Diseases 15(1) (2015)
Masanori Atsukawa; Akihito Tsubota; Noritomo Shimada; Kai Yoshizawa; Hiroshi Abe; Toru Asano; Yusuke Ohkubo; Masahiro Araki; Tadashi Ikegami; Chisa Kondo; Norio Itokawa; Ai Nakagawa; Taeang Arai; Yoko Matsushita; Katsuhisa Nakatsuka; Tomomi Furihata; Yoshimichi Chuganji; Yasushi Matsuzaki; Yoshio Aizawa; Katsuhiko Iwakiri
Vitamin D supplementation for chronic liver diseases in adults
Cochrane Database of Systematic Reviews 2017(11) (2017)
Goran Bjelakovic; Dimitrinka Nikolova; Marko Bjelakovic; Christian Gluud
Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C
Journal of Gastroenterology and Hepatology 30(9) (2015)
Yoshie Omori‐Mizuno; Nobuaki Nakayama; Mie Inao; Junji Funyu; Shinichi Asabe; Kengo Tomita; Kou Nishikawa; Yasuo Hosoda; Masahiko Tanaka; Yoshiaki Hashimoto; Koji Yakabi; Yohei Koshima; Satoshi Mochida
Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?
Gastroenterology & Hepatology: Open Access 5(8) (2016)
Samar Kamal Darweesh
Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?
European Journal of Gastroenterology & Hepatology 30(7) (2018)
Chao-Nan Jin; Jing-Dan Chen; Ji-Fang Sheng
Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis
Journal of Hepatology 61(6) (2014)
Matthew T. Kitson; Christoph Sarrazin; Pierluigi Toniutto; Guy D. Eslick; Stuart K. Roberts
The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan
Hepatitis Monthly 18(5) (2018)
Norio Itokawa; Masanori Atsukawa; Akihito Tsubota; Hiroshi Abe; Noritomo Shimada; Tomomi Okubo; Taeang Arai; Ai Nakagawa; Chisa Kondo; Yoshio Aizawa; Katsuhiko Iwakiri
Development of Interferon-Free, Direct-Acting Antivirals Treatment for Japanese Patients with Chronic Hepatitis C Infection and Chronic Kidney Disease
Journal of Nippon Medical School 88(3) (2021)
Masanori Atsukawa; Chisa Kondo; Tadamichi Kawano; Tomomi Okubo; Taeang Arai; Ai Nakagawa-Iwashita; Norio Itokawa; Katsuhiko Iwakiri
Vitamin D supplementation for chronic liver diseases in adults
Cochrane Database of Systematic Reviews 2021(10) (2021)
Milica Bjelakovic; Dimitrinka Nikolova; Goran Bjelakovic; Christian Gluud
Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19
Terapevticheskii arkhiv 93(8) (2021)
Olga A. Gromova; Ivan I. Torshin; Alexander G. Chuchalin; Elena N. Kozhevnikova; Svetlana I. Malyavskaya